This result is in contrast with the results of a previous study that reported markedly reduced percentages of TH22 cells and IL-22 levels in CRC patients, compared with those of healthy controls that were negatively associated with the pathological stages of CRC (139). Here, IL22 is linked to colorectal carcinoma.